|
|
|
|
|
Development of a Scaleable and Productive Insect Cell Culture Based Process for Making Flublok, The First FDA Licensed Recombinant Influenza Vaccine
Barry Buckland, Senior Advisor, Protein Sciences
11:30 am, Wednesday, October 28, 2015
Hear from Barry Buckland about the journey to the manufacture of the first recombinant influenza vaccine. The vaccine is manufactured using a the bacculovirus expression system and insect cell culture, that can be scaled up to large volumes for seasonal or pandemic influenza.
Listen Now.
|
|
|
|
Modeling of Glycosylation –
Predicting Profiles of Glycosylation from Metabolic Data
Michael Butler, Professor, University of Manitoba
1:30 pm, Tuesday, October 27, 2015
This podcast previews three methods to control glycosylation. Professor Butler describes the work of the INSERC Strategic Network for Production of Single-Type Glycoform Monoclonal Antibodies, including the tools and methods used in the study.
Listen Now.
|
|
|
|
High-Throughput Multi-Parametric Clone Screening Approach for the Generation of Tailored Production Cell Lines
Trent Munro, Principal Scientist, Amgen
8:05 am, Tuesday, October 27, 2015
In his presentation, Munro will share the methods Amgen has developed and techniques for increasing throughput for cell line development. In this podcast he describes the parameters and process behind this work.
Listen Now.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This message comes to you from BioProcess International, One Research Drive, Suite 400A, Westborough, MA 01581.
If you would prefer not to receive further messages from this sender, please click on the following link to unsubscribe:
Click here to opt out
|
 
|
|
|
©2014 BioProcess International All Rights reserved
|
|
